NYSE:NVO (Novo Nordisk)
About NVO
Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Biopharm segments. The Diabetes and Obesity Care segment includes insulin, GLP-1 and related delivery systems, oral antidiabetic products (OAD), obesity, and other serious chronic diseases. The Biopharm segment focuses on rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.
Novo Nordisk (NYSE: NVO) Latest News
Investing Articles
I asked ChatGPT if an AI bubble will trigger the next stock market crash
Investing Articles
After crashing 50%+, is this a bargain-basement growth stock?
Investing Articles
Should I buy Fundsmith Equity for my Stocks and Shares ISA?
Investing Articles
£20,000 Stocks and Shares ISA: how long would it take to reach £1 million?
Investing Articles
2 top dividend stocks to consider for passive income in May
Dividend Shares
3 world-class dividend stocks to consider for passive income
Investing Articles
I broke my 2025 Stocks and Shares ISA plan by buying this stock while it was down 60%
Investing Articles
Here’s how investing just £200 a month could create a chunky SIPP portfolio
Investing Articles
2 value stocks to consider after the recent sell-off
Investing Articles
Are these the best US stocks to consider buying right now?
Investing Articles
Is Fundsmith Equity still a good choice for a Stocks and Shares ISA in 2025?